Bright Minds Biosciences ... (DRUG)
NASDAQ: DRUG
· Real-Time Price · USD
31.67
-0.03 (-0.09%)
At close: May 15, 2025, 3:59 PM
32.55
2.79%
After-hours: May 15, 2025, 07:49 PM EDT
-0.09% (1D)
| Bid | 30 |
| Market Cap | 223.05M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.06M |
| EPS (ttm) | -0.14 |
| PE Ratio (ttm) | -226.18 |
| Forward PE | -10.78 |
| Analyst | Buy |
| Ask | 34.5 |
| Volume | 13,972 |
| Avg. Volume (20D) | 37,191 |
| Open | 31.76 |
| Previous Close | 31.70 |
| Day's Range | 31.07 - 32.56 |
| 52-Week Range | 0.93 - 79.02 |
| Beta | 1.19 |
About DRUG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRUG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-1.24%
Bright Minds Biosciences shares are trading higher...
Unlock content with
Pro Subscription
6 months ago
+1.72%
Bright Minds Biosciences shares are trading higher after the company announced a collaboration with Firefly Neuroscience to provide a full analysis of the EEG data in the BREAKTHROUGH study.
